Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Arrhythmias

Free Subscription Articles published in Heart Retrieve available abstracts of 179 articles: HTML format

Single Articles

March 2024
1. SOORAMPALLY V, Veeraraghavan S, Kidambi BR
   Dyspnoea, dizziness and dysrhythmia in a middle-aged patient.
   Heart. 2024;110:559-614.
   PubMed    
   
   
   
2. ISHIKITA A, McIntosh C, Roche SL, Barron DJ, et al
   Incremental value of machine learning for risk prediction in tetralogy of Fallot.
   Heart. 2024;110:560-568.
   PubMed     Abstract available
   
   
   
3. VINTER N, Cordsen P, Johnsen SP, Benjamin EJ, et al
   Birth cohort effects on diagnosed atrial fibrillation incidence: nationwide cohort study from 1980 to 2018.
   Heart. 2024 Mar 12:heartjnl-2023-323737. doi: 10.1136/heartjnl-2023-323737.
   PubMed     Abstract available
   
   
   
4. SAMUEL M, Rienstra M
   Birth cohort effect in atrial fibrillation: a matter of detection?
   Heart. 2024 Mar 12:heartjnl-2024-323950. doi: 10.1136/heartjnl-2024-323950.
   PubMed    
   
   
   January 2024
5. VAN HATTUM JC, Daems JJN, Verwijs SM, Wismans LV, et al
   Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports.
   Heart. 2024;110:254-262.
   PubMed     Abstract available
   
   
   
6. LAMBIASE PD
   Determining risk of sudden death: is it all in the T wave?
   Heart. 2024;110:151-153.
   PubMed    
   
   
   
7. HNATKOVA K, Andrsova I, Novotny T, Vanderberk B, et al
   QRS complex and T wave planarity for the efficacy prediction of automatic implantable defibrillators.
   Heart. 2024;110:178-187.
   PubMed     Abstract available
   
   
   
8. MAASS AH
   Inequities in access and use of automated external defibrillators.
   Heart. 2024;110:154-155.
   PubMed    
   
   
   
9. VAN DER VELDEN RMJ, Bonander C, Crijns HJGM, Kemp-Gudmundsdottir K, et al
   Adherence to a handheld device-based atrial fibrillation screening protocol is associated with clinical outcomes.
   Heart. 2024 Jan 5:heartjnl-2023-323522. doi: 10.1136/heartjnl-2023-323522.
   PubMed     Abstract available
   
   
   December 2023
10. JOHANSSON M, Fedorowski A
    Situational vs vasovagal syncope: one but different?
    Heart. 2023;110:3-4.
    PubMed    
    
    
    
11. SATURI G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, et al
    Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
    Heart. 2023;110:40-48.
    PubMed     Abstract available
    
    
    November 2023
12. FREDERIKSEN TC, Christiansen MK, Benjamin EJ, Overvad K, et al
    Interaction of genetic risk and lifestyle on the incidence of atrial fibrillation.
    Heart. 2023 Nov 28:heartjnl-2023-323333. doi: 10.1136/heartjnl-2023-323333.
    PubMed     Abstract available
    
    
    
13. VAZIR A, Kapelios CJ
    Sleep-disordered breathing and cardiovascular disease: who and why to test and how to intervene?
    Heart. 2023;109:1864-1870.
    PubMed     Abstract available
    
    
    
14. LAWIN D, Stellbrink C, Stellbrink E, Buck B, et al
    Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
    Heart. 2023;109:1778-1784.
    PubMed     Abstract available
    
    
    
15. BAROUTIDOU A, Arvanitaki A, Farmakis IT, Patsiou V, et al
    Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis.
    Heart. 2023;109:1741-1750.
    PubMed     Abstract available
    
    
    
16. OTTO CM
    Heartbeat: atrial fibrillation phenotyping identifies patients at high risk of adverse events.
    Heart. 2023;109:1725-1726.
    PubMed    
    
    
    October 2023
17. OTTO CM
    Heartbeat: ultra-processed foods and atrial fibrillation risk.
    Heart. 2023;109:1651-1653.
    PubMed    
    
    
    
18. FERKH A, Clark A, Thomas L
    Left atrial phasic function: physiology, clinical assessment and prognostic value.
    Heart. 2023;109:1661-1669.
    PubMed     Abstract available
    
    
    
19. CHA MJ, Lee SA, Cho MS, Nam GB, et al
    Reduction of moderate to severe tricuspid regurgitation after catheter ablation for atrial fibrillation.
    Heart. 2023 Oct 25:heartjnl-2023-323244. doi: 10.1136/heartjnl-2023-323244.
    PubMed     Abstract available
    
    
    
20. TEIGER E, Eschalier R, Amabile N, Rioufol G, et al
    Left atrial appendage closure in very elderly patients in the French National Registry.
    Heart. 2023 Oct 9:heartjnl-2023-322871. doi: 10.1136/heartjnl-2023-322871.
    PubMed     Abstract available
    
    
    September 2023
21. LOPEZ-LIZARRAGA MA, Sanchez-Amaya DJ, Godinez-Cordova LB
    Paradoxical worsening of an arrhythmia due to antiarrhythmics.
    Heart. 2023;109:1515-1576.
    PubMed    
    
    
    
22. AKERSTROM F, Hutter J, Charitakis E, Tabrizi F, et al
    Association between catheter ablation of atrial fibrillation and mortality or stroke.
    Heart. 2023 Sep 1:heartjnl-2023-322883. doi: 10.1136/heartjnl-2023-322883.
    PubMed     Abstract available
    
    
    August 2023
23. THAKUR A, Kumar S
    Palpitations in a young man after heavy work.
    Heart. 2023;109:1356-1418.
    PubMed    
    
    
    
24. GRIFFIN JM
    Sex differences in cardiac sarcoidosis.
    Heart. 2023;109:1346-1347.
    PubMed    
    
    
    
25. ISO T, Maeda D, Matsue Y, Dotare T, et al
    Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis.
    Heart. 2023;109:1387-1393.
    PubMed     Abstract available
    
    
    
26. CHATTERJEE NA, Rea TD
    Shortening time to defibrillation in shockable cardiac arrest matters: how do we do it?
    Heart. 2023;109:1344-1345.
    PubMed    
    
    
    
27. PONNUSAMY SS, Syed T, Vijayaraman P
    Pacing induced cardiomyopathy: recognition and management.
    Heart. 2023;109:1407-1415.
    PubMed     Abstract available
    
    
    
28. DZESHKA MS, Shantsila A, Shantsila E, Lip GYH, et al
    Better blood pressure control in patients with atrial fibrillation: overcoming barriers to improve outcomes.
    Heart. 2023 Aug 17:heartjnl-2023-323028. doi: 10.1136/heartjnl-2023-323028.
    PubMed    
    
    
    July 2023
29. ANDRADE JG, Deyell MW, Bennett R, Macle L, et al
    Assessment and management of asymptomatic atrial fibrillation.
    Heart. 2023 Jul 28:heartjnl-2023-322428. doi: 10.1136/heartjnl-2023-322428.
    PubMed     Abstract available
    
    
    
30. ANTIPEROVITCH P, Skanes A, Klein G, Tang A, et al
    Approach to a patient with asymptomatic pre-excitation.
    Heart. 2023;109:1254-1259.
    PubMed    
    
    
    
31. SAU A, Pastika L, Ng FS
    Atrial fibrillation phenotypes: the route to personalised care?
    Heart. 2023 Jul 24:heartjnl-2023-322812. doi: 10.1136/heartjnl-2023-322812.
    PubMed    
    
    
    
32. LAMBIASE PD, Maclean E
    Review of the National Institute for Health and Care Excellence guidelines on the management of atrial and ventricular arrhythmias.
    Heart. 2023 Jul 24:heartjnl-2022-322122. doi: 10.1136/heartjnl-2022-322122.
    PubMed     Abstract available
    
    
    
33. HALL R, Raju H, Nalliah C
    Association of diet with atrial fibrillation: villain or sidekick.
    Heart. 2023 Jul 21:heartjnl-2023-322897. doi: 10.1136/heartjnl-2023-322897.
    PubMed    
    
    
    
34. TRIVEDI R, Marschner S, Shaw T, Min H, et al
    Factors influencing blood pressure control in patients with atrial fibrillation and hypertension in Australian primary care.
    Heart. 2023 Jul 20:heartjnl-2023-322602. doi: 10.1136/heartjnl-2023-322602.
    PubMed     Abstract available
    
    
    
35. BEGGS SAS, Wright GA, Gardner RS
    Primary prevention implantable cardioverter defibrillators for patients with heart failure.
    Heart. 2023 Jul 18:heartjnl-2022-321728. doi: 10.1136/heartjnl-2022-321728.
    PubMed    
    
    
    
36. TU SJ, Gallagher C, Elliott AD, Bradbury KE, et al
    Associations of dietary patterns, ultra-processed food and nutrient intake with incident atrial fibrillation.
    Heart. 2023 Jul 17:heartjnl-2023-322412. doi: 10.1136/heartjnl-2023-322412.
    PubMed     Abstract available
    
    
    
37. AFOKE J, Camacho E, Bagameri G
    Recurrent ventricular arrhythmia after aortic root replacement and mitral valve repair.
    Heart. 2023;109:1145-1192.
    PubMed    
    
    
    
38. KOLDENHOF T, Van Gelder IC, Crijns HJ, Rienstra M, et al
    Rate control in atrial fibrillation, calcium channel blockers versus beta-blockers.
    Heart. 2023 Jul 11:heartjnl-2023-322635. doi: 10.1136/heartjnl-2023-322635.
    PubMed     Abstract available
    
    
    
39. AL-AIDAROUS S, Protonotarios A, Elliott PM, Lambiase PD, et al
    Management of arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2023 Jul 11:heartjnl-2023-322612. doi: 10.1136/heartjnl-2023-322612.
    PubMed     Abstract available
    
    
    June 2023
40. OTTO CM
    Heartbeat: prediction of atrial fibrillation risk.
    Heart. 2023;109:1045-1047.
    PubMed    
    
    
    
41. KHAN I, Atoot A
    Patient with altered mental status.
    Heart. 2023;109:1063-1122.
    PubMed    
    
    
    
42. CAI H, Chen G, Hu W, Jiang C, et al
    Anticoagulant in atrial fibrillation patients with prior intracranial haemorrhage: a meta-analysis.
    Heart. 2023 Jun 15:heartjnl-2023-322492. doi: 10.1136/heartjnl-2023-322492.
    PubMed     Abstract available
    
    
    
43. BANCHS J, Lech T
    Cardiovascular phenotypes and incident cardiovascular events in people with previous cancer.
    Heart. 2023;109:974-976.
    PubMed    
    
    
    
44. BEVAN G, Nazer B
    Exercise and arrhythmogenic cardiomyopathy: all things in moderation.
    Heart. 2023;109:972-973.
    PubMed    
    
    
    
45. RAMOS-MAQUEDA J, Migueles JH, Molina-Jimenez M, Ruiz-Gonzalez D, et al
    Lifestyle physical activity and rapid-rate non-sustained ventricular tachycardia in arrhythmogenic cardiomyopathy.
    Heart. 2023;109:992-999.
    PubMed     Abstract available
    
    
    
46. SAITO Y, Omae Y, Nagashima K, Miyauchi K, et al
    Phenotyping of atrial fibrillation with cluster analysis and external validation.
    Heart. 2023 Jun 1:heartjnl-2023-322447. doi: 10.1136/heartjnl-2023-322447.
    PubMed     Abstract available
    
    
    May 2023
47. BHATIA RT, Malhotra A, MacLachlan H, Gati S, et al
    Prevalence and diagnostic significance of de-novo 12-lead ECG changes after COVID-19 infection in elite soccer players.
    Heart. 2023;109:936-943.
    PubMed     Abstract available
    
    
    April 2023
48. HATIPOGLU S, Gardezi SKM, Azzu A, Baksi J, et al
    Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
    Heart. 2023;109:748-755.
    PubMed     Abstract available
    
    
    
49. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
    Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
    Heart. 2023;109:771-778.
    PubMed     Abstract available
    
    
    
50. RAISI-ESTABRAGH Z, Cooper J, McCracken C, Crosbie EJ, et al
    Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer.
    Heart. 2023 Apr 18:heartjnl-2022-321888. doi: 10.1136/heartjnl-2022-321888.
    PubMed     Abstract available
    
    
    
51. KARAM N, Spaulding C
    Interventional management of out-of-hospital cardiac arrest.
    Heart. 2023;109:719-722.
    PubMed    
    
    
    
52. PINTO-FILHO MM, Paixao GM, Gomes PR, Soares CPM, et al
    Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study.
    Heart. 2023;109:668-673.
    PubMed     Abstract available
    
    
    
53. DIEDERICHSEN SZ, Svennberg E
    Novel path: FINDing the way forward in screening for atrial fibrillation.
    Heart. 2023 Apr 5:heartjnl-2023-322395. doi: 10.1136/heartjnl-2023-322395.
    PubMed    
    
    
    
54. FLORIA M, Tanase DM
    Bradyarrhythmias in patients with atrial fibrillation.
    Heart. 2023 Apr 3:heartjnl-2023-322498. doi: 10.1136/heartjnl-2023-322498.
    PubMed    
    
    
    March 2023
55. MULLER SA, Te Riele ASJM
    Implantable cardioverter-defibrillator shocks during long-term follow-up in arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2023 Mar 28:heartjnl-2022-322138. doi: 10.1136/heartjnl-2022-322138.
    PubMed    
    
    
    
56. MARON MS, Rowin E, Spirito P, Maron BJ, et al
    Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
    Heart. 2023;109:589-594.
    PubMed     Abstract available
    
    
    
57. AHN HJ, Lee SR, Choi EK, Lee SW, et al
    Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA(2)DS(2)-VASc scores.
    Heart. 2023 Mar 24:heartjnl-2022-322143. doi: 10.1136/heartjnl-2022-322143.
    PubMed     Abstract available
    
    
    
58. FRAUSING MHJP, Van De Lande ME, Maass AH, Nguyen BO, et al
    Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation.
    Heart. 2023 Mar 22:heartjnl-2022-322253. doi: 10.1136/heartjnl-2022-322253.
    PubMed     Abstract available
    
    
    
59. MOLITOR N, Hofer D, Cimen T, Gasperetti A, et al
    Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2023 Mar 16:heartjnl-2022-321739. doi: 10.1136/heartjnl-2022-321739.
    PubMed     Abstract available
    
    
    
60. FINK T, Sciacca V, Sommer P
    Catheter ablation of atrial fibrillation after percutaneous left atrial appendage closure: friend or foe?
    Heart. 2023 Mar 1:heartjnl-2023-322374. doi: 10.1136/heartjnl-2023-322374.
    PubMed    
    
    
    February 2023
61. SPECTERMAN MJ, Behr ER
    Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death.
    Heart. 2023;109:434-441.
    PubMed     Abstract available
    
    
    
62. BORSCHEL CS, Ortega-Alonso A, Havulinna AS, Jousilahti P, et al
    Inflammatory proteomics profiling for prediction of incident atrial fibrillation.
    Heart. 2023 Feb 17:heartjnl-2022-321959. doi: 10.1136/heartjnl-2022-321959.
    PubMed     Abstract available
    
    
    
63. NADARAJAH R, Wu J, Hogg D, Raveendra K, et al
    Prediction of short-term atrial fibrillation risk using primary care electronic health records.
    Heart. 2023 Feb 9:heartjnl-2022-322076. doi: 10.1136/heartjnl-2022-322076.
    PubMed     Abstract available
    
    
    
64. CHEN JJ, Chiu FC, Chang SN, Cheng HL, et al
    Impact of pre-existing left atrial appendage occluder on catheter ablation of atrial fibrillation.
    Heart. 2023 Feb 7:heartjnl-2022-321934. doi: 10.1136/heartjnl-2022-321934.
    PubMed     Abstract available
    
    
    
65. KIM J, Kim D, Jang E, Kim D, et al
    Associations of high-normal blood pressure and impaired fasting glucose with atrial fibrillation.
    Heart. 2023 Feb 7:heartjnl-2022-322094. doi: 10.1136/heartjnl-2022-322094.
    PubMed     Abstract available
    
    
    January 2023
66. OTTO CM
    Heartbeat: prevention of atrial fibrillation progression.
    Heart. 2023;109:159-161.
    PubMed    
    
    
    
67. JOY M, Williams J, Emanuel S, Kar D, et al
    Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014-2019).
    Heart. 2023;109:195-201.
    PubMed     Abstract available
    
    
    
68. LINZ D, Schnabel RB
    Gut microbiota-derived metabolites in atrial fibrillation: risk markers or modifiable risk factors?
    Heart. 2023 Jan 2:heartjnl-2022-321806. doi: 10.1136/heartjnl-2022-321806.
    PubMed    
    
    
    
69. ABDULSALAM NM, Poole JE
    When will we learn? Differential outcomes in women following catheter ablation of atrial fibrillation.
    Heart. 2023 Jan 2:heartjnl-2022-322092. doi: 10.1136/heartjnl-2022-322092.
    PubMed    
    
    
    
70. LUCIANI M, Muller D, Vanetta C, Diteepeng T, et al
    Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation.
    Heart. 2023 Jan 2:heartjnl-2022-321300. doi: 10.1136/heartjnl-2022-321300.
    PubMed     Abstract available
    
    
    December 2022
71. ANDERSON RH, Garbi M, Zugwitz D, Petersen SE, et al
    Anatomy of the mitral valve relative to controversies concerning the so-called annular disjunction.
    Heart. 2022 Dec 30:heartjnl-2022-322043. doi: 10.1136/heartjnl-2022-322043.
    PubMed     Abstract available
    
    
    
72. PELLEGRINI CN, Buzkova P, Oesterle A, Heckbert SR, et al
    Dysregulated carbohydrate and lipid metabolism and risk of atrial fibrillation in advanced old age.
    Heart. 2022 Dec 22:heartjnl-2022-321633. doi: 10.1136/heartjnl-2022-321633.
    PubMed     Abstract available
    
    
    
73. ARPS K, Piccini JP
    Women, men and the safety gap after catheter ablation of atrial fibrillation.
    Heart. 2022 Dec 22:heartjnl-2022-321632. doi: 10.1136/heartjnl-2022-321632.
    PubMed    
    
    
    
74. LOPEZ-LIZARRAGA MA, Ezquerra-Osorio A, Cueva-Parra A
    Woman with alternating QRS in the emergency department: what is happening?
    Heart. 2022;109:95-158.
    PubMed    
    
    
    
75. BULARGA A, Newby DE, Chapman AR
    Not to be sneezed at: cardiovascular disease after COVID-19 infection.
    Heart. 2022;109:84-85.
    PubMed    
    
    
    
76. SCARSINI R, Pighi M, Mainardi A, Portolan L, et al
    Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis.
    Heart. 2022 Dec 13:heartjnl-2022-321907. doi: 10.1136/heartjnl-2022-321907.
    PubMed     Abstract available
    
    
    November 2022
77. WILKINSON C, Rockwood K
    Frailty assessment in the management of cardiovascular disease.
    Heart. 2022;108:1991-1995.
    PubMed    
    
    
    
78. GUPTA D, Ding WY, Calvert P, Williams E, et al
    Cryoballoon Pulmonary Vein Isolation as First-Line Treatment for Typical Atrial Flutter.
    Heart. 2022 Nov 17. pii: heartjnl-2022-321729. doi: 10.1136/heartjnl-2022-321729
    PubMed     Abstract available
    
    
    
79. WEBER C, Hung J, Hickling S, Li I, et al
    Emergent readmission and long-term mortality risk after incident atrial fibrillation hospitalisation.
    Heart. 2022 Nov 16. pii: heartjnl-2022-321560. doi: 10.1136/heartjnl-2022-321560
    PubMed     Abstract available
    
    
    
80. WALDMANN V, Khairy P
    Atrial fibrillation in Ebstein anomaly: weathering the storm.
    Heart. 2022 Nov 15. pii: heartjnl-2022-321876. doi: 10.1136/heartjnl-2022-321876
    PubMed    
    
    
    
81. MARTIN DE MIGUEL I, Madhavan M, Miranda WR, Connolly HM, et al
    Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.
    Heart. 2022 Nov 11. pii: heartjnl-2022-321493. doi: 10.1136/heartjnl-2022-321493
    PubMed     Abstract available
    
    
    
82. BURSI F, Lee AP
    Strain and mitral regurgitation: is atrial functional mitral regurgitation a ventricular disease?
    Heart. 2022 Nov 11. pii: heartjnl-2022-321945. doi: 10.1136/heartjnl-2022-321945
    PubMed    
    
    
    
83. KITAI T, Nabeta T, Naruse Y, Taniguchi T, et al
    Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis.
    Heart. 2022;108:1887-1894.
    PubMed     Abstract available
    
    
    
84. AEBERSOLD H, Serra-Burriel M, Foster-Wittassek F, Moschovitis G, et al
    Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort.
    Heart. 2022 Nov 4. pii: heartjnl-2022-321520. doi: 10.1136/heartjnl-2022-321520.
    PubMed     Abstract available
    
    
    October 2022
85. CASO V, de Groot JR, Sanmartin Fernandez M, Segura T, et al
    Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2022 Oct 31. pii: heartjnl-2022-321114. doi: 10.1136/heartjnl-2022-321114
    PubMed     Abstract available
    
    
    
86. LANE DJ, Grunau B, Kudenchuk P, Dorian P, et al
    Bayesian analysis of amiodarone or lidocaine versus placebo for out-of-hospital cardiac arrest.
    Heart. 2022;108:1777-1783.
    PubMed     Abstract available
    
    
    
87. MEUCCI MC, Stassen J, Tomsic A, Palmen M, et al
    Prognostic impact of left ventricular global longitudinal strain in atrial mitral regurgitation.
    Heart. 2022 Oct 21. pii: heartjnl-2022-321698. doi: 10.1136/heartjnl-2022-321698
    PubMed     Abstract available
    
    
    
88. LYNGBAKKEN MN, Ronningen PS, Solberg MG, Berge T, et al
    Prediction of incident atrial fibrillation with cardiac biomarkers and left atrial volumes.
    Heart. 2022 Oct 19. pii: heartjnl-2022-321608. doi: 10.1136/heartjnl-2022-321608
    PubMed     Abstract available
    
    
    
89. RAMLAKHAN KP, Kauling RM, Schenkelaars N, Segers D, et al
    Supraventricular arrhythmia in pregnancy.
    Heart. 2022;108:1674-1681.
    PubMed     Abstract available
    
    
    September 2022
90. HENDRIKS JM, Elliott AD, Middeldorp ME, Sanders P, et al
    Contributing factors to personalised medicine in atrial fibrillation.
    Heart. 2022 Sep 29. pii: heartjnl-2022-321553. doi: 10.1136/heartjnl-2022-321553
    PubMed    
    
    
    
91. LAWIN D, Lawrenz T, Marx K, Danielsmeier NB, et al
    Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Heart. 2022;108:1623-1628.
    PubMed     Abstract available
    
    
    
92. MSZAR R, Friedman DJ, Ong E, Du C, et al
    Sex-based differences in atrial fibrillation ablation adverse events.
    Heart. 2022 Sep 14. pii: heartjnl-2022-321192. doi: 10.1136/heartjnl-2022-321192
    PubMed     Abstract available
    
    
    
93. MARSCHNER S, von Huben A, Zaman S, Reynolds HR, et al
    Pregnancy-related cardiovascular conditions and outcomes in a United States Medicaid population.
    Heart. 2022;108:1524-1529.
    PubMed     Abstract available
    
    
    August 2022
94. VAN DER VELDEN RMJ, Pluymaekers NAHA, Dudink EAMP, Luermans JGLM, et al
    Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation.
    Heart. 2022 Aug 29. pii: heartjnl-2022-321346. doi: 10.1136/heartjnl-2022-321346
    PubMed     Abstract available
    
    
    
95. SANCHEZ-QUINTANA D, Anderson RH, Tretter JT, Cabrera JA, et al
    Anatomy of the conduction tissues 100 years on: what have we learned?
    Heart. 2022;108:1430-1437.
    PubMed     Abstract available
    
    
    July 2022
96. PARALE C, Velayutham R, Anantharaj A
    Tachycardia in a young man: does pulse oximetry give a clue?
    Heart. 2022;108:1266-1330.
    PubMed    
    
    
    
97. NGUYEN BO, Weberndorfer V, Crijns HJ, Geelhoed B, et al
    Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation.
    Heart. 2022 Jul 20. pii: heartjnl-2022-321027. doi: 10.1136/heartjnl-2022-321027
    PubMed     Abstract available
    
    
    
98. VILALTA V, Cediel G, Mohammadi S, Lopez H, et al
    New-onset persistent left bundle branch block following sutureless aortic valve replacement.
    Heart. 2022 Jul 16. pii: heartjnl-2022-321191. doi: 10.1136/heartjnl-2022-321191
    PubMed     Abstract available
    
    
    
99. KANY S, Cardoso VR, Bravo L, Williams JA, et al
    Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Heart. 2022 Jul 14. pii: heartjnl-2022-321196. doi: 10.1136/heartjnl-2022-321196
    PubMed     Abstract available
    
    
    
100. KIM HJ, Chang DH, Kim SO, Kim JK, et al
     Left atrial appendage preservation versus closure during surgical ablation of atrial fibrillation.
     Heart. 2022 Jul 13. pii: heartjnl-2022-320939. doi: 10.1136/heartjnl-2022-320939
     PubMed     Abstract available
     
     
     June 2022
101. MARROQUIN L, Tirado-Conte G, Pracon R, Streb W, et al
     Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.
     Heart. 2022;108:1098-1106.
     PubMed     Abstract available
     
     
     
102. AVILA P, Calvo D, Tamargo M, Uribarri A, et al
     Association of age with clinical features and ablation outcomes of paroxysmal supraventricular tachycardias.
     Heart. 2022;108:1107-1113.
     PubMed     Abstract available
     
     
     
103. TAN HL, Remme CA
     Sudden cardiac death: recognising hidden risk among women versus men.
     Heart. 2022;108:992-993.
     PubMed    
     
     
     May 2022
104. KUDENCHUK PJ
     Management of cardiac arrest in the cardiac catheterisation laboratory: guidelines tailored to place and occasion.
     Heart. 2022;108:907-908.
     PubMed    
     
     
     
105. OTTO CM
     Heartbeat: can cardiogenetics reduce adverse events due to catecholaminergic polymorphic ventricular tachycardia?
     Heart. 2022;108:816-818.
     PubMed    
     
     
     
106. POSTEMA PG, van der Werf C
     Catecholaminergic polymorphic ventricular tachycardia: differences in inheritance and implications for patients, families and future studies.
     Heart. 2022;108:820-821.
     PubMed    
     
     
     
107. SHIMAMOTO K, Ohno S, Kato K, Takayama K, et al
     Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1.
     Heart. 2022;108:840-847.
     PubMed     Abstract available
     
     
     
108. MARSMAN EMJ, Postema PG, Remme CA
     Brugada syndrome: update and future perspectives.
     Heart. 2022;108:668-675.
     PubMed     Abstract available
     
     
     
109. HAYDOCK P, Camm AJ
     History and evolution of pacing and devices.
     Heart. 2022;108:794-799.
     PubMed     Abstract available
     
     
     April 2022
110. ROSEBOOM E, Maass AH
     Inherited and modifiable factors need to be identified in young patients with atrioventricular block.
     Heart. 2022 Apr 5. pii: heartjnl-2022-320841. doi: 10.1136/heartjnl-2022-320841.
     PubMed    
     
     
     
111. KOMEN J, Pottegard A, Hjemdahl P, Mantel-Teeuwisse AK, et al
     Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.
     Heart. 2022;108:613-618.
     PubMed     Abstract available
     
     
     
112. MORITA S, Malik AH, Kuno T, Ando T, et al
     Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
     Heart. 2022;108:606-612.
     PubMed     Abstract available
     
     
     
113. HOLT A, Blanche P, Zareini B, Rasmussen PV, et al
     Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants.
     Heart. 2022;108:626-632.
     PubMed     Abstract available
     
     
     
114. HIGUCHI K, Bhargava M
     Management of premature ventricular complexes.
     Heart. 2022;108:565-572.
     PubMed    
     
     
     March 2022
115. PARK YJ, Park JW, Yu HT, Kim TH, et al
     Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs.
     Heart. 2022 Mar 24. pii: heartjnl-2021-320601. doi: 10.1136/heartjnl-2021-320601
     PubMed     Abstract available
     
     
     
116. RAATIKAINEN P, Lassila R
     COVID-19: another reason for anticoagulation in patients with atrial fibrillation.
     Heart. 2022 Mar 21. pii: heartjnl-2022-320845. doi: 10.1136/heartjnl-2022-320845
     PubMed    
     
     
     
117. GILL S, Bunting KV, Sartini C, Cardoso VR, et al
     Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis.
     Heart. 2022 Mar 11. pii: heartjnl-2021-320417. doi: 10.1136/heartjnl-2021-320417
     PubMed     Abstract available
     
     
     
118. HANDY A, Banerjee A, Wood AM, Dale C, et al
     Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
     Heart. 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325
     PubMed     Abstract available
     
     
     
119. DYSSEKILDE JR, Christiansen MK, Johansen JB, Nielsen JC, et al
     Familial risk of atrioventricular block in first-degree relatives.
     Heart. 2022 Mar 4. pii: heartjnl-2021-320411. doi: 10.1136/heartjnl-2021-320411.
     PubMed     Abstract available
     
     
     
120. FRANKE KB, Mahajan R
     Cardiac oxidative stress: a potential tool for risk stratification in cardiac sarcoidosis.
     Heart. 2022;108:410-411.
     PubMed    
     
     
     
121. YOSHITOMI R, Kobayashi S, Yano Y, Nakashima Y, et al
     Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
     Heart. 2022;108:429-437.
     PubMed     Abstract available
     
     
     February 2022
122. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
     Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
     Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
     PubMed     Abstract available
     
     
     
123. OTTO CM
     Heartbeat: bleeding risk in atrial fibrillation patients on non-vitamin K oral anticoagulant medications.
     Heart. 2022;108:243-245.
     PubMed    
     
     
     
124. GUPTA A, Arora GK, Isser HS
     An elderly woman with recurrent syncope.
     Heart. 2022;108:257-324.
     PubMed    
     
     
     
125. MORRONE D, De Caterina R
     Bleeding risk score: limits and practicability.
     Heart. 2022;108:246-248.
     PubMed    
     
     
     January 2022
126. TUTAREL O, Baris L, Budts W, Gamal Abd-El Aziz M, et al
     Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC).
     Heart. 2022;108:117-123.
     PubMed     Abstract available
     
     
     
127. VITALE G, Ditaranto R, Graziani F, Tanini I, et al
     Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.
     Heart. 2022;108:54-60.
     PubMed     Abstract available
     
     
     December 2021
128. OTTO CM
     Heartbeat: lower risk of dementia with a direct oral anticoagulatant, compared to a vitamin K antagonist, for patients with atrial fibrillation.
     Heart. 2021;107:1847-1849.
     PubMed    
     
     
     
129. DING WY, Mahida S
     Wide complex tachycardia: differentiating ventricular tachycardia from supraventricular tachycardia.
     Heart. 2021;107:1995-2003.
     PubMed    
     
     
     November 2021
130. OTTO CM
     Heartbeat: ECG approaches to early detection of atrial fibrillation.
     Heart. 2021;107:1765-1767.
     PubMed    
     
     
     October 2021
131. HIMELFARB JD, Shulman H, Olesovsky CJ, Rumman RK, et al
     Atrial fibrillation following transcatheter atrial septal defect closure: a systematic review and meta-analysis.
     Heart. 2021 Oct 21. pii: heartjnl-2021-319794. doi: 10.1136/heartjnl-2021-319794
     PubMed     Abstract available
     
     
     
132. DEYELL MW, Hawkins NM
     Odd couple: premature ventricular contractions and heart failure.
     Heart. 2021 Oct 19. pii: heartjnl-2021-319986. doi: 10.1136/heartjnl-2021-319986
     PubMed    
     
     
     
133. CADOGAN SL, Powell E, Wing K, Wong AY, et al
     Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
     Heart. 2021 Oct 13. pii: heartjnl-2021-319672. doi: 10.1136/heartjnl-2021-319672
     PubMed     Abstract available
     
     
     
134. CHUA W
     Clearing the cognitive cloud: direct oral anticoagulants or vitamin K antagonists for reducing dementia risk in patients with atrial fibrillation?
     Heart. 2021 Oct 13. pii: heartjnl-2021-320138. doi: 10.1136/heartjnl-2021-320138
     PubMed    
     
     
     
135. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
     Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
     Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
     PubMed     Abstract available
     
     
     
136. ZAMAN J, Agarwal S
     Management of ventricular tachycardia storm.
     Heart. 2021;107:1671-1677.
     PubMed    
     
     
     September 2021
137. BARNETT-GRINESS O, Stein N, Kotler A, Saliba W, et al
     Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants.
     Heart. 2021 Sep 21. pii: heartjnl-2021-319702. doi: 10.1136/heartjnl-2021-319702
     PubMed     Abstract available
     
     
     
138. KASHOU A, Noseworthy P
     Predicting incident atrial fibrillation in sinus rhythm: more than just trusting the 'black box'.
     Heart. 2021 Sep 7. pii: heartjnl-2021-319385. doi: 10.1136/heartjnl-2021-319385.
     PubMed    
     
     
     
139. LIMPITIKUL WB, Dewland TA, Vittinghoff E, Soliman E, et al
     Premature ventricular complexes and development of heart failure in a community-based population.
     Heart. 2021 Sep 7. pii: heartjnl-2021-319473. doi: 10.1136/heartjnl-2021-319473.
     PubMed     Abstract available
     
     
     
140. NASER JA, Pislaru S, Stan MN, Lin G, et al
     Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease.
     Heart. 2021 Sep 6. pii: heartjnl-2021-319752. doi: 10.1136/heartjnl-2021-319752.
     PubMed     Abstract available
     
     
     August 2021
141. BLAAUW Y, Mulder B, Rienstra M
     Is catheter ablation of atrial fibrillation as first-line treatment ready for prime time?
     Heart. 2021 Aug 12. pii: heartjnl-2021-319832. doi: 10.1136/heartjnl-2021-319832
     PubMed    
     
     
     
142. KANY S, Schnabel R
     Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation.
     Heart. 2021 Aug 12. pii: heartjnl-2021-319830. doi: 10.1136/heartjnl-2021-319830
     PubMed    
     
     
     
143. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
     Refined atrial fibrillation screening and cost-effectiveness in the German population.
     Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
     PubMed     Abstract available
     
     
     
144. TOOLEY JE, Perez MV
     Role of digital health in detection and management of atrial fibrillation.
     Heart. 2021 Aug 3. pii: heartjnl-2020-318262. doi: 10.1136/heartjnl-2020-318262.
     PubMed     Abstract available
     
     
     
145. OTTO CM
     Heartbeat: improved quality of life and reduced healthcare utilisation after catheter ablation in patients with drug-resistant paroxysmal atrial fibrillation.
     Heart. 2021;107:1271-1273.
     PubMed    
     
     
     July 2021
146. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
     Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
     Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
     PubMed     Abstract available
     
     
     
147. IMBERTI JF, Ding WY, Kotalczyk A, Zhang J, et al
     Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis.
     Heart. 2021 Jul 14. pii: heartjnl-2021-319496. doi: 10.1136/heartjnl-2021-319496
     PubMed     Abstract available
     
     
     
148. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
     Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
     Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
     PubMed     Abstract available
     
     
     June 2021
149. CHEN TH, Chu YC, Ou SM, Tarng DC, et al
     Associations of atrial fibrillation with renal function decline in patients with chronic kidney disease.
     Heart. 2021 Jun 30. pii: heartjnl-2021-319297. doi: 10.1136/heartjnl-2021-319297
     PubMed     Abstract available
     
     
     
150. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
     Update on management of atrial fibrillation in heart failure: a focus on ablation.
     Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
     PubMed     Abstract available
     
     
     
151. SANZ-GARCIA A, Cecconi A, Vera A, Camarasaltas JM, et al
     Electrocardiographic biomarkers to predict atrial fibrillation in sinus rhythm electrocardiograms.
     Heart. 2021 Jun 4. pii: heartjnl-2021-319120. doi: 10.1136/heartjnl-2021-319120.
     PubMed     Abstract available
     
     
     
152. MINNERS J, Jander N
     Consecutive, index and representative beats: obtaining reliable information despite an irregular heart rhythm.
     Heart. 2021;107:862-863.
     PubMed    
     
     
     
153. BRIGNOLE M, Rivasi G
     New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope.
     Heart. 2021;107:864-873.
     PubMed     Abstract available
     
     
     
154. PARKER WA, Storey RF
     Antithrombotic therapy for patients with chronic coronary syndromes.
     Heart. 2021;107:925-933.
     PubMed    
     
     
     May 2021
155. WILDE AAM, Amin AS, Postema PG
     Diagnosis, management and therapeutic strategies for congenital long QT syndrome.
     Heart. 2021 May 26. pii: heartjnl-2020-318259. doi: 10.1136/heartjnl-2020-318259
     PubMed     Abstract available
     
     
     
156. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
     Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
     Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
     PubMed     Abstract available
     
     
     
157. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
     Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
     Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
     PubMed     Abstract available
     
     
     
158. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
     Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
     Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
     PubMed     Abstract available
     
     
     
159. ELVAN A
     It's all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation.
     Heart. 2021 May 20. pii: heartjnl-2021-319382. doi: 10.1136/heartjnl-2021-319382
     PubMed    
     
     
     
160. BOSMAN LP, Te Riele ASJM
     Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
     Heart. 2021 May 14. pii: heartjnl-2021-319113. doi: 10.1136/heartjnl-2021-319113
     PubMed     Abstract available
     
     
     
161. CHOI Y, Lee Y, Kim SH, Kim S, et al
     Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
     Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
     PubMed     Abstract available
     
     
     
162. GUPTA D, Ding WY
     Contemporary management of persistent atrial fibrillation.
     Heart. 2021 May 14. pii: heartjnl-2020-317422. doi: 10.1136/heartjnl-2020-317422
     PubMed    
     
     
     
163. CHUA W, Fabritz L
     Heart failure in patients with atrial fibrillation: why it matters now more than ever.
     Heart. 2021 May 13. pii: heartjnl-2021-319145. doi: 10.1136/heartjnl-2021-319145
     PubMed    
     
     
     
164. RUTHERFORD OW, Jonasson C, Ghanima W, Soderdahl F, et al
     Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation.
     Heart. 2021 May 11. pii: heartjnl-2020-318753. doi: 10.1136/heartjnl-2020-318753
     PubMed     Abstract available
     
     
     
165. GUPTA D, Vijgen J, Potter T, Scherr D, et al
     Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
     Heart. 2021 May 5. pii: heartjnl-2020-318676. doi: 10.1136/heartjnl-2020-318676.
     PubMed     Abstract available
     
     
     
166. JOLOBE O
     Next frontier is inclusion of high-grade carotid artery stenosis in the CHA2DS2 Vasc score.
     Heart. 2021;107:767.
     PubMed    
     
     
     
167. KARTHIKEYAN G
     Stroke risk in rheumatic heart disease.
     Heart. 2021;107:694-696.
     PubMed    
     
     
     
168. FAN P, Zhang Y, Lu YT, Yang KQ, et al
     Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
     Heart. 2021;107:836-841.
     PubMed     Abstract available
     
     
     April 2021
169. SANTOS IS, Bensenor IM
     Cardiovascular health and atrial fibrillation.
     Heart. 2021 Apr 15. pii: heartjnl-2021-319253. doi: 10.1136/heartjnl-2021-319253
     PubMed    
     
     
     
170. LEE JH, Yang PS, Yu HT, Kim TH, et al
     Association of cardiovascular health and incident atrial fibrillation in elderly population.
     Heart. 2021 Apr 2. pii: heartjnl-2020-318858. doi: 10.1136/heartjnl-2020-318858.
     PubMed     Abstract available
     
     
     
171. YEO C, Wang Y, Tan VH
     Wide complex tachycardia captured on smartwatch.
     Heart. 2021;107:626-684.
     PubMed    
     
     
     
172. GEURINK K, Holmes D, Ezekowitz MD, Pieper K, et al
     Patterns of oral anticoagulation use with cardioversion in clinical practice.
     Heart. 2021;107:642-649.
     PubMed     Abstract available
     
     
     
173. SPARROW R, Sanjoy S, Choi YH, Elgendy IY, et al
     Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure.
     Heart. 2021 Apr 1. pii: heartjnl-2020-318650. doi: 10.1136/heartjnl-2020-318650.
     PubMed     Abstract available
     
     
     February 2021
174. SINNING CR
     Biomarkers for detection of a thrombus in the left atrial appendage: the search for the grail?
     Heart. 2021;107:176-177.
     PubMed    
     
     
     January 2021
175. SINGH T, Newby DE
     Is the fear of disease worse than the disease itself?
     Heart. 2021;107:91-92.
     PubMed    
     
     
     October 2020
176. MULDER BA, Rienstra M, Blaauw Y
     Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction.
     Heart. 2020 Oct 19. pii: heartjnl-2020-317491. doi: 10.1136/heartjnl-2020-317491
     PubMed     Abstract available
     
     
     September 2020
177. IHSAN J, Khand A, Adlan AM
     Ventricular storm following late presentation acute myocardial infarction.
     Heart. 2020;106:1399-1448.
     PubMed    
     
     
     May 2020
178. KIM WK, Kim HJ, Kim JB, Jung SH, et al
     Exclusion versus preservation of the left atrial appendage in rheumatic mitral valve surgery.
     Heart. 2020 May 6. pii: heartjnl-2019-316387. doi: 10.1136/heartjnl-2019-316387.
     PubMed     Abstract available
     
     
     January 2020
179. TAN TC, Nunes MCP, Handschumacher M, Pontes-Neto O, et al
     Left atrial cross-sectional area is a novel measure of atrial shape associated with cardioembolic strokes.
     Heart. 2020 Jan 24. pii: heartjnl-2019-315964. doi: 10.1136/heartjnl-2019-315964
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.